Estonian Icebreaker.vc invests in Swedish medtech startup Cytely

Estonian Icebreaker.vc participated in a €3M seed round for Swedish startup Cytely, led by Ugly Duckling Ventures.

Cytely is a deeptech startup focused on accelerating discovery to unlock human biology and cure all preventable disease. The company's smart-microscopy platform turns images into data, quantifying thousands of cells per run, automating acquisition, and standardizing analysis so researchers can discover and iterate faster. Built with transparent methods and a modern web interface, Cytely powers the shift to data-centric workflows and works with any modern microscope. The company was founded in 2023 in Lund, Sweden. Founders: Philip Nordenfelt (CEO), Johannes Kumra Ahnlide (CTO), Oscar André (CPO) & Pontus Nordenfelt (CSO - Chief Scientific Officer).

The new funding will enable Cytely to accelerate scientific discoveries by making intelligent microscopy accessible to any laboratory.

Icebreaker.vc is a venture capital firm that invests in innovative startups, including those in the fields of software, hardware, and deep tech. The company's mission is to support and empower entrepreneurs who create innovative solutions to pressing global issues. Its portfolio includes companies such as Valpas, Lumoa, Workfellow, and Oterlu. Founded in Helsinki in 2016 by Riku Seppälä, Lasse Lehtinen, Aleksi Partanen.

Ugly Duckling Ventures is a venture capital firm from Denmark, founded in 2021. Its goal is to provide financing to early-stage startups in the Scandinavian region, particularly in Denmark and Iceland. Investment areas: mobility, XR (extended reality), and AR (augmented reality).